Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05238142 · ClinicalTrials.gov registry record · NA
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 574
- Enrollment target
NCT05238142: Completed NA study, sponsored by Medtronic MiniMed.
NCT05238142 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 574 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05238142, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 574 participants
- Enrollment target
Study Summary
The objective of the study is to assess the safety and effectiveness of MiniMed™ 780G system in adult subjects with insulin-requiring type 2 diabetes in a home setting. The combined run-in period and study period will be approximately 135 days long.
Interventions
- DEVICE MiniMed™ 780G Insulin Pump system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 574 participants |
| Start Date | 2022-02-25 |
| Est. Completion | 2025-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05238142
The ClinicalTrials.gov registry entry for NCT05238142 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 574 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MiniMed™ 780G Insulin Pump system is the first listed.
NCT05238142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05238142 about?
NCT05238142 is a clinical study titled "In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes". The objective of the study is to assess the safety and effectiveness of MiniMed™ 780G system in adult subjects with insulin-requiring type 2 diabetes in a home setting. The combined run-in period and study period will be approximately 135 days long.
What is the current status of trial NCT05238142?
This trial is currently completed. It is a NA study. The enrollment target is 574 participants. The study started on 2022-02-25. Estimated completion is 2025-01-11.
What interventions are being tested in trial NCT05238142?
The interventions under investigation include: MiniMed™ 780G Insulin Pump system (DEVICE).
Who is sponsoring clinical trial NCT05238142?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.